Yesterday, PEPFAR, Janssen Pharmaceutica NV and ViiV Healthcare announced a combined $85 million investment to support 56 DREAMS Innovation Challenge winners in 10 sub-Saharan African countries. Of this investment, $40 million is focused on keeping girls in secondary school, which dramatically reduces their vulnerability to HIV infection, and nearly half of these education-focused resources are directed to Malawi.
|
|
